TABLE OF CONTENTS
Volume 24, Issue 22 (19 May 2005)
Commentary
Uncovering MYC's full oncogenic potential in the hematopoietic system
Siegfried Janz
Oncogene 24: 3541-3543; advance online publication, March 21, 2005; doi:10.1038/sj.onc.1208473
Original Papers
T-cell lymphomas mask slower developing B-lymphoid and myeloid tumours in transgenic mice with broad haemopoietic expression of MYC
Darrin P Smith, Mary L Bath, Alan W Harris and Suzanne Cory
Oncogene 24: 3544-3553; advance online publication, January 31, 2005; doi:10.1038/sj.onc.1208399
Promotion of mammary cancer development by tamoxifen in a mouse model of Brca1-mutation-related breast cancer
Laundette P Jones, Minglin Li, Ewa D Halama, Yongxian Ma, Ronald Lubet, Clinton J Grubbs, Chu-Xia Deng, Eliot M Rosen and Priscilla A Furth
Oncogene 24: 3554-3562; advance online publication, March 7, 2005; doi:10.1038/sj.onc.1208426
p53 must be competent for transcriptional regulation to suppress tumor formation
Monica Nistér, Mengjia Tang, Xiao-Qun Zhang, Chaoying Yin, Michelle Beeche, Xinrong Hu, Gunilla Enblad, Terry van Dyke and Geoffrey M Wahl
Oncogene 24: 3563-3573; advance online publication, March 7, 2005; doi:10.1038/sj.onc.1208354
Positive feedback regulation between AKT activation and fatty acid synthase expression in ovarian carcinoma cells
Hui Qin Wang, Deborah A Altomare, Kristine L Skele, Poulikos I Poulikakos, Francis P Kuhajda, Antonio Di Cristofano and Joseph R Testa
Oncogene 24: 3574-3582; advance online publication, April 4, 2005; doi:10.1038/sj.onc.1208463
Cell-autonomous induction of functional tumor suppressor 15-lipoxygenase 2 (15-LOX2) contributes to replicative senescence of human prostate progenitor cells
Bobby Bhatia, Shaohua Tang, Peiying Yang, Andreas Doll, Gerhard Aumüeller, Robert A Newman and Dean G Tang
Oncogene 24: 3583-3595; advance online publication, March 7, 2005; doi:10.1038/sj.onc.1208406
Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth
Lincoln A Edwards, B Thiessen, Wieslawa H Dragowska, Tim Daynard, Marcel B Bally and Shoukat Dedhar
Oncogene 24: 3596-3605; advance online publication, March 21, 2005; doi:10.1038/sj.onc.1208427
YB-1 facilitates basal and 5-fluorouracil-inducible expression of the human major vault protein (MVP) gene
Ulrike Stein, Stephan Bergmann, George L Scheffer, Rik J Scheper, Hans-Dieter Royer, Peter M Schlag and Wolfgang Walther
Oncogene 24: 3606-3618; advance online publication, March 7, 2005; doi:10.1038/sj.onc.1208386
Differential roles for the coactivators CBP and p300 on TCF/
-catenin-mediated survivin gene expression
Hong Ma, Cu Nguyen, Kyung-Soon Lee and Michael Kahn
Oncogene 24: 3619-3631; advance online publication, March 14, 2005; doi:10.1038/sj.onc.1208433
Vasculostatin, a proteolytic fragment of Brain Angiogenesis Inhibitor 1, is an antiangiogenic and antitumorigenic factor
Balveen Kaur, Daniel J Brat, Narra S Devi and Erwin G Van Meir
Oncogene 24: 3632-3642; advance online publication, March 14, 2005; doi:10.1038/sj.onc.1208317
c-FMS chromatin structure and expression in normal and leukaemic myelopoiesis
George Alexander Follows, Hiromi Tagoh, Stephen John Richards, Svitlana Melnik, Helen Dickinson, Erica de Wynter, Pascal Lefevre, Gareth John Morgan and Constanze Bonifer
Oncogene 24: 3643-3651; advance online publication, April 4, 2005; doi:10.1038/sj.onc.1208655
Increased prevalence of the BRCA2 polymorphic stop codon K3326X among individuals with familial pancreatic cancer
Sean T Martin, Hiroyuki Matsubayashi, Carmelle D Rogers, Juliet Philips, Fergus J Couch, Kieran Brune, Charles J Yeo, Scott E Kern, Ralph H Hruban and Michael Goggins
Oncogene 24: 3652-3656; advance online publication, April 4, 2005; doi:10.1038/sj.onc.1208411
Modulation of CDK2-AP1 (p12DOC-1) expression in human colorectal cancer
Ziquan Yuan, Anu G Gaba, Tara Sotsky Kent, Anna Bennett, Agnes Miller and Thomas K Weber
Oncogene 24: 3657-3668; advance online publication, April 4, 2005; doi:10.1038/sj.onc.1208378
Induction of apoptosis by the synthetic retinoid MX3350-1 through extrinsic and intrinsic pathways in head and neck squamous carcinoma cells
Kyung-Hee Chun, Magnus Pfahl and Reuben Lotan
Oncogene 24: 3669-3677; advance online publication, March 21, 2005; doi:10.1038/sj.onc.1208339
Short Reports
Mutations of the PU.1 Ets domain are specifically associated with murine radiation-induced, but not human therapy-related, acute myeloid leukaemia
Nirosha Suraweera, Emmy Meijne, John Moody, Luis G Carvajal-Carmona, Kazuko Yoshida, Patrick Pollard, Jude Fitzgibbon, Andrew Riches, Theo van Laar, Rene Huiskamp, Andrew Rowan, Ian P M Tomlinson and Andrew Silver
Oncogene 24: 3678-3683; advance online publication, March 7, 2005; doi:10.1038/sj.onc.1208422
Connexin32 as a tumor suppressor gene in a metastatic renal cell carcinoma cell line
Eriko Fujimoto, Hiromi Sato, Sumiko Shirai, Yoji Nagashima, Keiko Fukumoto, Hiromi Hagiwara, Etsuko Negishi, Koichi Ueno, Yasufumi Omori, Hiroshi Yamasaki, Kiyokazu Hagiwara and Tomohiro Yano
Oncogene 24: 3684-3690; advance online publication, March 14, 2005; doi:10.1038/sj.onc.1208430
Genetic interactions between RAD51 and its paralogues for centrosome fragmentation and ploidy control, independently of the sensitivity to genotoxic stresses
Fayza Daboussi, John Thacker and Bernard S Lopez
Oncogene 24: 3691-3696; advance online publication, March 21, 2005; doi:10.1038/sj.onc.1208438